| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/13/2007 | CN1320926C Ginkgo leaf extract composition and its prepn |
| 06/13/2007 | CN1320922C Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
| 06/13/2007 | CN1320918C Miao medicine for treating tuberculosis and rheumatic heart disease and its compounding process and usage |
| 06/13/2007 | CN1320904C Xuefuzhuyu drop pills and preparing technique |
| 06/13/2007 | CN1320890C Ginkgo medicine composition, its preparing method and its use |
| 06/13/2007 | CN1320886C Use of ainfbutamone and anticonvulsant in preparation of treating obesity drug |
| 06/13/2007 | CN1320885C Enapoli maleate dispersion tablet and its preparation technology |
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230102 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 06/12/2007 | US7230088 Compounds for dual photodiagnosis and therapy |
| 06/12/2007 | US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230019 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 06/12/2007 | US7230011 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht6 receptor |
| 06/12/2007 | US7230009 Pyridoxal analogues and methods of treatment |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229993 Aryl substituted pyrimidines and the use thereof |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229982 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; for treatment of atheroslerosis |
| 06/12/2007 | US7229969 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 06/12/2007 | US7229649 Method and composition for improving sexual fitness |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/12/2007 | CA2198005C Pyrazolo[3,4-g]quinoxaline compounds which inhibit pdgf receptor protein tyrosine kinase |
| 06/12/2007 | CA2184065C Inhibition of arterial smooth muscle cell proliferation |
| 06/12/2007 | CA2173418C Benzonitriles and benzofluorides |
| 06/12/2007 | CA1341530C Inhibitors of angiogenin |
| 06/08/2007 | CA2539874A1 Novel uses of scleraxis |
| 06/07/2007 | WO2007064274A1 Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid |
| 06/07/2007 | WO2007063946A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/07/2007 | WO2007063839A1 Cyclohexane derivative |
| 06/07/2007 | WO2007063822A1 Acid addition salt of dihydropyridine derivative |
| 06/07/2007 | WO2007063821A1 Acid addition salt of optically active dihydropyridine derivative |
| 06/07/2007 | WO2007063789A1 Novel catechol derivative, pharmaceutical composition containing same, and uses of those |
| 06/07/2007 | WO2007062676A1 Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists |
| 06/07/2007 | WO2007062594A1 Neuregulin variants and methods of screening and using thereof |
| 06/07/2007 | WO2007048353B1 Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases |
| 06/07/2007 | WO2007048027A3 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 06/07/2007 | WO2007043653A9 Benzimidazole-5-carboxamide derivative |
| 06/07/2007 | WO2007041076A3 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 06/07/2007 | WO2007024472A3 USE OF PAR- l/PAR- 4 INHIBITORS FOR TREATING OR PREVENTING VASCULAR DISEASES |
| 06/07/2007 | WO2006127907A3 Localized delivery of cardiac inotropic agents |
| 06/07/2007 | US20070130629 Renal Regulatory Elements and Methods of Use Thereof |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129371 Novel ethylenediamine derivatives |
| 06/07/2007 | US20070129357 Novel crystals of fluorobenzamide derivative |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |
| 06/07/2007 | US20070129296 Cardiac muscle function and manipulation |
| 06/07/2007 | US20070129289 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128292 rich in polyunsaturated fatty acids such as linolenic acid, eicosapentaenoic acid, docosahexaenoic acid and antioxidant; cardiovascular diseases |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128163 Adeno-associated virus-mediated delivery of angiogenic factors |
| 06/07/2007 | US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | CA2632152A1 Neuregulin variants and methods of screening and using thereof |
| 06/07/2007 | CA2631826A1 Acid addition salt of dihydropyridine derivative |
| 06/07/2007 | CA2631822A1 Acid addition salt of optically active dihydropyridine derivative |
| 06/07/2007 | CA2628907A1 Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid |
| 06/07/2007 | CA2568825A1 Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases |
| 06/06/2007 | EP1793006A2 Nucleic acid ligands and improved methods for producing the same |
| 06/06/2007 | EP1792985A1 Cell fusion promoter and utilization of the same |
| 06/06/2007 | EP1792915A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2007 | EP1792616A1 Composition comprising an HMG-CoA inhibitor and a nicotinic acid compound for treating hyperlipidemia |
| 06/06/2007 | EP1792611A1 Matrix controlled transdermal system for stable derivatives of ACE inhibitors |
| 06/06/2007 | EP1791977A2 Methods for assessing atherosclerosis |
| 06/06/2007 | EP1791841A1 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity |
| 06/06/2007 | EP1791832A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 06/06/2007 | EP1791813A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 06/06/2007 | EP1791600A1 Combination of organic compounds |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1791547A1 Oral formulations of paricalcitol |
| 06/06/2007 | EP1791528A1 Lyophilisate containing n-diaminomethylene-2-methyl-4,5-di-(methylsulfonyl)-benzamide |
| 06/06/2007 | EP1619962B1 Composition for oral administration containing capsaicinoids |
| 06/06/2007 | EP1542666B1 Modafinil pharmaceutical compositions |
| 06/06/2007 | EP1496894A4 Angiogenesis inhibitors |
| 06/06/2007 | EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 06/06/2007 | EP1363874B1 Tryptase inhibitors |
| 06/06/2007 | EP1354046B1 Regulation of expression of eer-7, a member of the lysyl oxidase gene family, by estrogen receptors |
| 06/06/2007 | EP1289556B1 Isoflavones against radiation-induced mortality |
| 06/06/2007 | DE102005050498A1 Cyclopropylessigsäure-Derivate und ihre Verwendung Cyclopropylacetic acid derivatives and their use |
| 06/06/2007 | CN1976945A Isopeptide gap junction modulators |
| 06/06/2007 | CN1976924A Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists |
| 06/06/2007 | CN1976919A Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto |
| 06/06/2007 | CN1976683A Oral sustained release formulation of tedisamil with gastric retention properties |
| 06/06/2007 | CN1974594A Human myocardial troponin I subunit nucleic acid adaptor and its application |
| 06/06/2007 | CN1973917A Electrothermal cap for dredging cerebral meridian and its making process |
| 06/06/2007 | CN1973875A Process of extracting Tatine compounds from Puer tea and the product |
| 06/06/2007 | CN1973867A Chinese medicine prepn for treating arrhythmia |
| 06/06/2007 | CN1973865A Medicine composition for treating apoplexy and its prepn |
| 06/06/2007 | CN1973835A Use of ammidin in preparing medicine for treating cadiac and cerebral vasular diseases |
| 06/06/2007 | CN1973833A Transdermal cyclovirobuxine prepn for treating cardiac and cerebral vascular diseases and its prepn process |
| 06/06/2007 | CN1973828A VEGF slowly releasing injection microsphere support and its prepn and use |